Clinical Trial Update: Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents [Phase 2]

View source ↗

Summary

A completed Phase II trial evaluating the combination of cisplatin and temozolomide for malignant glial tumors in children and adolescents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Glioma | Phase 2 | Status: COMPLETED